glp-1 vertigo meds like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular GLP-1 Agonists: A Comprehensive Overview
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




















